What next for botulism vaccine development?-Reference-Cited by-同舟云学术

What next for botulism vaccine development?

Published:2013-05 Issue:5 Volume:12 Page:481-492
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Webb Robert P,Smith Leonard A

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.1586/erv.13.37

Reference87 articles.

1. Johnson EA.Clostridium botulinumandClostridium tetani. In:Topley and Wilson’s Microbiology and Microbial Infections. Volume 8. Borriello SP, Murray PR, Funke G (Eds). Hodder Arnold Publishers, London, UK, 1035–1088 (2005).

2. Crystal Structure of Botulinum Neurotoxin Type A in Complex with the Cell Surface Co-Receptor GT1b—Insight into the Toxin–Neuron Interaction

3. SV2 Is the Protein Receptor for Botulinum Neurotoxin A

4. The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

5. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulism;2024-03-19

2. Tetanus toxin and botulinum neurotoxin–derived fusion molecules are effective bivalent vaccines;Applied Microbiology and Biotechnology;2023-09-23

3. Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines;Toxins;2023-09-08

4. Biological and Immunological Characterization of a Functional L-HN Derivative of Botulinum Neurotoxin Serotype F;Toxins;2023-03-06

5. Specific Methods for the Destruction of Hazardous Chemicals in the Laboratory;Destruction of Hazardous Chemicals in the Laboratory;2023-01-13